GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
2.7k
c/survodutide·posted 1 year ago by u/kaia_wojcik

is it normal to get muscle cramps at week 88

Trial Data Cold Box ×5 Long Haul ×3 Receipts ×1

Check-in as promised in the title: is it normal to get muscle cramps at week 88.

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use.

Independent purity results for this compound are very sparse across the whole site, which means any impression about consistency is built on almost nothing.

Screenshot none of this. Read the whole thread, including the parts where I am told I am wrong.

3,149 up / 489 down87% upvoted32 commentsid 1wnabx12 Mar 2025

32 comments

9 in this archive, depth 4

best — the order this archive was captured in

u/patient_labslip_log261 points·1 year ago

the titration in the trials was slow and deliberate

replysharereportpermalink
u/sofia_ferreira-38 points·1 year ago

Disagree — that is a weight endpoint from a different programme and you are quoting it in a hepatic context.

replysharereportpermalink
u/milan_mensah1 point·1 year ago

This. Biopsy-confirmed and imaging-suggested are different evidentiary categories and get run together constantly.

replysharereportpermalink
u/kaia_wojcikOP1 point·1 year ago

Small fix — dual agonist, GLP-1 and glucagon. No GIP arm in this molecule.

replysharereportpermalink
u/kaia_wojcikOP0 points·1 year ago

Which endpoint — histological response, fibrosis improvement, or fat fraction?

replysharereportpermalink
u/honest_syringe_pls1 point·1 year ago

Correction: that is the imaging endpoint, not the histological one. The paper reports both and they differ substantially.

replysharereportpermalink
u/paper_trail_paulavetting1 point·1 year ago

That figure is from the obesity programme, and this thread is about the hepatic one.

replysharereportpermalink
u/incretin_ivyMOD258 points·1 year ago

Retitled to name the endpoint. Histological and imaging results are not interchangeable and the original title implied they were.

replysharereportpermalink
u/kaia_wojcikOP129 points·1 year ago

Correcting myself: the readout I quoted was the 4-week interim rather than the endpoint.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.